Detection of Metastatic Tumor Cells in the Bone Marrow Aspirate Smears by Artificial Intelligence (AI)-Based Morphogo System.
Source check: Source checked. Not independent scientific confirmation.
Finding: In 60 patients, Morphogo AUC was 0.865; sensitivity/specificity varied by threshold and human pathologists remained more sensitive at the high-specificity threshold. Organization is unavailable in the deposited bibliographic metadata.
Technology: Morphogo deep-learning image-analysis system
Publication: Publication status unspecified in annotation · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Morphogo deep-learning image analysis identified metastatic carcinoma clusters in bone-marrow aspirate smears.
- Test and result
- In 60 patients, Morphogo AUC was 0.865; sensitivity/specificity varied by threshold and human pathologists remained more sensitive at the high-specificity threshold.
- Limitation / still unknown
- The reviewed study does not establish validation or benefit beyond its reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.742395/full
The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.